Open access

Second-Line Chemotherapy for Platinum- and Taxane-Resistant Epithelial Ovarian Cancer: Pegylated Liposomal Doxorubicin (PLD), Irinotecan, and Combination Therapies at Lower Doses

Written By

Toru Sugiyama

Submitted: March 1st, 2011 Published: February 15th, 2012

DOI: 10.5772/28554

Chapter metrics overview

1,834 Chapter Downloads

View Full Metrics

Written By

Toru Sugiyama

Submitted: March 1st, 2011 Published: February 15th, 2012